Thomas Lazzarini is an Ophthalmology physician. OpenAlex indexes 24 publications with 439 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202515 payments
- Apellis Pharmaceuticals, Inc.Program year20253 payments
- Genentech USA, Inc.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Choroideremia presenting as vision loss secondary to choroidal neovascularization
Ophthalmic Genetics
2023 - Patients With Dragged Optic Disc Vessels and Retinal Folds: Clinical Features, Multimodal Imaging, and Histopathology
Ophthalmic surgery, lasers & imaging retina
2023 - Outcomes in Patients with Suprachoroidal Hemorrhage After Anterior Segment Surgery
Clinical ophthalmology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Robert Weinreb, MD
University of California San Diego
Emily Chew, MD
National Eye Institute
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”